RFID Opportunities in Healthcare in the U.S.

    Published: June 1, 2007 | Price: $1,995.00 – $7,990.00

    RFID (Radio Frequency IDentification) technologies are dramatically changing many industries, but as detailed in Kalorama's market research report RFID Opportunities in Healthcare in the U.S., the greatest market for RFID is in healthcare. Hospitals, pharmaceutical companies, nursing homes, and other healthcare entities will benefit from using the technologies to keep track of inventories and patients. What are the best markets within healthcare for RFID? How will benefits outweigh costs? How are these technologies best implemented? Who are the leading providers...
    Blood Screening and Typing Markets

    Published: January 20, 2016 | Price: $2,000.00 – $4,000.00

    Blood Screening and Typing Markets Blood Screening and Typing Markets analyzes the infectious disease blood typing and the infectious disease blood screening opportunities, including complete revenue estimates of the blood screening and typing markets: global blood typing and screening revenues, 2015 and 2020 (ABO grouping, immunoassay screen, NAT screen); selected blood typing innovations; blood typing by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); infectious disease blood typing market portion by...
    In Vitro Diagnostics Business Outlook, 2024 (6 updates)

    Published: December 20, 2024 | Price: $4,995.00 – $9,995.00

    In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually. In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including: ​ Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities​ A comprehensive view of the IVD market with test categories covered and company briefs​ M&A activities, selected partnerships & collaborations, partnership deals, and more Industry & region watch to help tailor strategies​ Analysis of news and events and reporting on...
    The Market for In Vitro Diagnostic Tests in Latin America: Forecasts to 2019 (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

    Published: January 31, 2015 | Price: $1,995.00 – $3,990.00

    The Market for IVD in Latin America The Market for IVD in Latin America is an essential resource for IVD companies seeking market information for developing countries with growing economies. Kalorama Information, and VA Consultadora y Asociados of Argentina have published detailed nation by nation market analysis of the IVD markets in LATAM and thier segment markets. Each country in Latin America is different in terms of their healthcare system, insurance services, laws and industry participants. For this reason, this...
    Cell and Gene Therapy Deals Analysis, 2021-2024

    Published: June 3, 2024 | Price: $6,300.00 – $12,600.00

    Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 is published in two installments, the first in Q2 2024 and the second in Q4 2024. Customers who purchase the report will receive both installments. Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that...
    U.S. Market for Molecular Diagnostics, 2nd Edition

    Published: May 1, 2004 | Price: $3,500.00 – $7,000.00

    Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based on molecular testing approaches. The primary molecular diagnostics approaches are based on two major database sciences (genomics and proteomics) and their relationship to disease and...
    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    Published: October 1, 2004 | Price: $995.00 – $1,990.00

    Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Down’s syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as...
    The Global Market for Medical Devices, 10th Edition (45 Specific Device Markets and 50 Country Markets Forecasted to 2024)

    Published: October 28, 2019 | Price: $4,000.00 – $8,000.00

    The Global Market for Medical Devices, 10th edition, provides a comprehensive view of the medical device market and opportunity for medical device manufacturers, competitors, and investors. The report examines the companies in the market, the types of devices sold across the global market, and the country markets they are sold in. As part of its coverage, this report contains market sizing and forecasts for the world medical device market and the medical device markets of 50 countries, providing the following...
    CT Systems: World Market Analysis, Forecasts to 2018

    Published: December 1, 2014 | Price: $995.00 – $1,990.00

    CT Systems: World Market Analysis Computed Tomography or CT systems has revolutionized imaging and diagnosis. CT scanners continously improve to allow for enhanced resolution, patient comfort and safety. Computed Tomography or CT systems blends software and-rays to obtain crossed images of the body. CT allows physicians to look at a patient from the inside. This study, Computed Tomography (CT) Systems: World Market Analysis features the following market information: Market Size Estimate Geographic Market Breakout (US, BRIC, Europe, Japan) Market Projection...
    Autism Therapeutics: A Market Briefing

    Published: January 15, 2005 | Price: $995.00 – $1,990.00

    Despite the traditional notion that nothing therapeutic can be accomplished for the 1.5 million Americans with autism and the 2 million more throughout the world, there are pharmacologic approaches to the disease that are providing some help for patients and garnering revenues for drug companies. This Market Briefing reviews the market for drugs used in the treatment of autism and related disorers, including Antidepressants, Anti-Anxiety drugs, Anti-psychotics, Anti-convulsants, and CNS stimulants for ADHD-related symptoms, forecasting revenues through 2009 gloabally and...
    The World Market for Neurotherapeutic Drugs

    Published: September 1, 2005 | Price: $3,500.00 – $7,000.00

    Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This Kalorama Information report focuses on several key product segments of neurotherapeutic treatment: Alzheimer’s Disease and Other Dementias Brain and Neurologic Cancers Brain Trauma and Stroke...
    Minimally Invasive Spinal Surgery – A Market Briefing

    Published: June 1, 2005 | Price: $995.00 – $1,990.00

    With the promise of improved outcomes and shorter recovery times and costs, endoscopic surgery has evolved into an accepted surgical discipline in most therapeutic areas. However, spine surgeons in particular have been slow to embrace this new technology over the past decade or so. Challenges specific to the spinal column have made the adoption of minimally invasive surgery difficult, but endoscope manufacturers have begun to take advantage of technological advances in endoscopic visualization and other arrears to optimize the minimal-access...
    Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition

    Published: July 13, 2023 | Price: $3,750.00 – $7,500.00

    A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type,...
    What’s Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

    Published: February 12, 2018 | Price: $4,500.00 – $9,000.00

    What's Trending in Monoclonal Antibodies (Markets by Structure, by Target, and by Indication) There are several types of monoclonal antibodies (mAbs) – large protein molecules produced by white blood cells (WBCs) that seek out and destroy harmful foreign substances – on the market and in development. What's Trending in Monoclonal Antibodies looks at the market for these, which are finding wide application in many areas of medicine and biologic science, by structure, by target, and by indication, including the following...
    Genetic Testing Markets for Epilepsy, Autism, Alzheimer’s and Other Neurologic Conditions

    Published: January 4, 2021 | Price: $4,000.00 – $8,000.00

    Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes for neurological conditions. The area of inherited condition testing for neurological conditions has become a major area of activity in the last decade or so,...